ConductScience.org, home

Comparison · NCT02467621-04887c15

Proton Pump Inhibitor (PPI) vs Normal Saline: Number of Participants With Clinically Important GI Bleeding, Pneumonia, Clostridium Difficile Infection or Acute Myocardial Ischemia

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Proton Pump Inhibitor (PPI) vs Normal Saline: Number of Participants With Clinically Important GI Bleeding, Pneumonia, Clostridium Difficile Infection or Acute Myocardial Ischemia. Trial comparisons, record NCT02467621-04887c15. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT02467621-04887c15

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.2190.20.24wilson
Risk in group 20.2260.2060.247wilson
Risk difference, group 1 minus group 2-0.00689-0.03530.0215newcombe hybrid score
Risk ratio, group 1 over group 20.970.8531.1log
Odds ratio, group 1 over group 20.9610.8151.13log
Number needed to treat, for one fewer participant with the outcome on Proton Pump Inhibitor (PPI) than on Normal Saline145from the risk difference intervalthe interval includes no difference

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Proton Pump Inhibitor (PPI)Pantoprazole 40 mg~Pantoprazole: 40 mg x 1 daily intravenously from ICU admission to ICU discharge3601,644OG000
Group 2Normal SalineSaline (0.9%)~Saline (0.9%): 10 ml of isotonic saline x 1 daily intravenously from ICU admission to ICU discharge3721,647OG001

Outcome

Type
SECONDARY
Title
Number of Participants With Clinically Important GI Bleeding, Pneumonia, Clostridium Difficile Infection or Acute Myocardial Ischemia
Description
Composite outcome of the number of participants with one or more of the mentioned conditions in the ICU
Time frame
Until ICU discharge, maximum 90 days
Population
Intention-to-treat

Source ClinicalTrials.gov

Trial

Title
Stress Ulcer Prophylaxis in the Intensive Care Unit
NCT number
NCT02467621
Phases
PHASE4
Conditions
Gastrointestinal Bleeding, Stress Ulcers
Interventions
Pantoprazole, Saline (0.9%)
Lead sponsor
Dr. Morten Hylander Møller
Results first posted
2019-06-07

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT02467621-04887c15